{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:54:40Z","timestamp":1785552880420,"version":"3.56.0"},"reference-count":219,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is a predominant malignancy with increasing incidences and mortalities worldwide. In Western countries, the progressive affirmation of Non-alcoholic Fatty Liver Disease (NAFLD) as the main chronic liver disorder in which HCC occurrence is appreciable even in non-cirrhotic stages, constitutes a real health emergency. In light of this, a further comprehension of molecular pathways supporting HCC onset and progression represents a current research challenge to achieve more tailored prognostic models and appropriate therapeutic approaches. RNA non-coding transcripts (ncRNAs) are involved in the regulation of several cancer-related processes, including HCC. When dysregulated, these molecules, conventionally classified as \u201csmall ncRNAs\u201d (sncRNAs) and \u201clong ncRNAs\u201d (lncRNAs) have been reported to markedly influence HCC-related progression mechanisms. In this review, we describe the main dysregulated ncRNAs and the relative molecular pathways involved in HCC progression, analyzing their implications in certain etiologically related contexts, and their applicability in clinical practice as novel diagnostic, prognostic, and therapeutic tools. Finally, given the growing evidence supporting the immune system response, the oxidative stress-regulated mechanisms, and the gut microbiota composition as relevant emerging elements mutually influencing liver-cancerogenesis processes, we investigate the relationship of ncRNAs with this triad, shedding light on novel pathogenetic frontiers of HCC progression.<\/jats:p>","DOI":"10.3390\/cancers15215178","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T09:56:36Z","timestamp":1698400596000},"page":"5178","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2970-9019","authenticated-orcid":false,"given":"Mario","family":"Romeo","sequence":"first","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Miraglia 2, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4153-815X","authenticated-orcid":false,"given":"Marcello","family":"Dallio","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Miraglia 2, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4215-9068","authenticated-orcid":false,"given":"Flavia","family":"Scognamiglio","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Miraglia 2, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2947-431X","authenticated-orcid":false,"given":"Lorenzo","family":"Ventriglia","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Miraglia 2, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cipullo","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Miraglia 2, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4818-9714","authenticated-orcid":false,"given":"Annachiara","family":"Coppola","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Miraglia 2, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tammaro","sequence":"additional","affiliation":[{"name":"Biochemistry Division, Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Miraglia 2, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Scafuro","sequence":"additional","affiliation":[{"name":"Biochemistry Division, Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Miraglia 2, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Iodice","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, AORN Azienda dei Colli, Monaldi Hospital, Via Leonardo Bianchi, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0885-0793","authenticated-orcid":false,"given":"Alessandro","family":"Federico","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Miraglia 2, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and Management of Hepatocellular Carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2015.07.018","article-title":"Heterogeneity of liver cancer and personalized therapy","volume":"379","author":"Li","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1478-3231.2007.01637.x","article-title":"Molecular pathogenesis of hepatocellular carcinoma","volume":"28","author":"Wong","year":"2008","journal-title":"Liver Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41467-019-14050-z","article-title":"Intratumoral heterogeneity and clonal evolution in liver cancer","volume":"11","author":"Losic","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11427-020-1700-9","article-title":"Non-coding RNAs: The new central dogma of cancer biology","volume":"64","author":"Saw","year":"2021","journal-title":"Sci. China. Life Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-42059-2_1","article-title":"Non-coding RNAs: Classification, Biology and Functioning","volume":"937","author":"Hombach","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The Role of Non-coding RNAs in Oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Giraud, J., Chalopin, D., Blanc, J.F., and Saleh, M. (2021). Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.655697"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2019.08.016","article-title":"Gut microbiome in HCC\u2014Mechanisms, diagnosis and therapy","volume":"72","author":"Schwabe","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/2211536607666180827111633","article-title":"MiRNAs: Biology, Biogenesis, their Web-based Tools, and Databases","volume":"8","author":"Tafrihi","year":"2019","journal-title":"MicroRNA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"174178","DOI":"10.1016\/j.ejphar.2021.174178","article-title":"siRNA: Mechanism of action, challenges, and therapeutic approaches","volume":"905","author":"Alshaer","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2741\/E595","article-title":"Regulation of hepatocarcinogenesis by microRNAs","volume":"5","author":"Wong","year":"2013","journal-title":"Front. Biosci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ruiz-Manriquez, L.M., Carrasco-Morales, O., Sanchez, Z.E., Osorio-Perez, S.M., Estrada-Meza, C., Pathak, S., Banerjee, A., Bandyopadhyay, A., Duttaroy, A.K., and Paul, S. (2022). MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.910733"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1566523214666141224095610","article-title":"miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir","volume":"15","author":"Thakral","year":"2015","journal-title":"Curr. Gene Ther."},{"key":"ref_16","first-page":"1175","article-title":"Suppressive role of microRNA-29 in hepatocellular carcinoma via targeting IGF2BP1","volume":"11","author":"Yang","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Yang, Y.L., Tsai, M.C., Chang, Y.H., Wang, C.C., Chu, P.Y., Lin, H.Y., and Huang, Y.H. (2021). MIR29A Impedes Metastatic Behaviors in Hepatocellular Carcinoma via Targeting LOX, LOXL2, and VEGFA. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22116001"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/hep.23380","article-title":"Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma","volume":"51","author":"Xiong","year":"2010","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/hep.26373","article-title":"MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42","volume":"58","author":"Wang","year":"2013","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12272-019-01153-w","article-title":"Targeting ROCK\/LIMK\/cofilin signaling pathway in cancer","volume":"42","author":"Lee","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21873\/cgp.20163","article-title":"MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance","volume":"17","author":"Weidle","year":"2020","journal-title":"Cancer Genom. Proteom."},{"key":"ref_22","first-page":"1992","article-title":"miR-497 inhibits the carcinogenesis of hepatocellular carcinoma by targeting the Rictor\/Akt signal pathway","volume":"12","author":"Zhang","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/hepr.12606","article-title":"Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review","volume":"46","author":"Mizuguchi","year":"2016","journal-title":"Hepatol. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1073\/pnas.0907904107","article-title":"miR-221 overexpression contributes to liver tumorigenesis","volume":"107","author":"Pineau","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.febslet.2011.02.031","article-title":"Down-regulation of miR-23b may contribute to activation of the TGF-\u03b21\/Smad3 signalling pathway during the termination stage of liver regeneration","volume":"585","author":"Yuan","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.biopha.2013.03.014","article-title":"MicroRNA-21 activates hepatic stellate cells via PTEN\/Akt signaling","volume":"67","author":"Wei","year":"2013","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13046-018-0965-2","article-title":"Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts","volume":"37","author":"Zhou","year":"2018","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/labinvest.2010.126","article-title":"Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans","volume":"90","author":"Marquez","year":"2010","journal-title":"Lab. Investig. A J. Technol. Methods Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"44050","DOI":"10.18632\/oncotarget.17211","article-title":"Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2217\/bmm-2018-0096","article-title":"Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma","volume":"12","author":"Yoon","year":"2018","journal-title":"Biomark. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Yerukala Sathipati, S., and Ho, S.Y. (2020). Novel miRNA signature for predicting the stage of hepatocellular carcinoma. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-71324-z"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s11033-011-0884-1","article-title":"Comprehensive gene and microRNA expression profiling reveals the crucial role of hsa-let-7i and its target genes in colorectal cancer metastasis","volume":"39","author":"Zhang","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejogrb.2022.03.005","article-title":"Study of serum miR-518 and its correlation with inflammatory factors in patients with gestational diabetes mellitus complicated with hypertensive disorder complicating pregnancy","volume":"272","author":"Li","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Chen, S.C., Huang, C.H., Lai, S.J., Yang, C.S., Hsiao, T.H., Lin, C.H., Fu, P.K., Ko, T.P., and Chen, Y. (2016). Mechanism and inhibition of human UDP-GlcNAc 2-epimerase, the key enzyme in sialic acid biosynthesis. Sci. Rep., 6.","DOI":"10.1038\/srep23274"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Morita, M., Nishida, N., Aoki, T., Chishina, H., Takita, M., Ida, H., Hagiwara, S., Minami, Y., Ueshima, K., and Kudo, M. (2023). Role of \u03b2-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma. Cancers, 15.","DOI":"10.3390\/cancers15082311"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.4149\/neo_2022_220727N774","article-title":"miR-550a-5p promotes the proliferation and migration of hepatocellular carcinoma by targeting GNE via the Wnt\/\u03b2-catenin signaling pathway","volume":"69","author":"Li","year":"2022","journal-title":"Neoplasma"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/carcin\/bgad037","article-title":"miR-424-3p promotes metastasis of hepatocellular carcinoma via targeting the SRF-STAT1\/2 axis","volume":"44","author":"Feng","year":"2023","journal-title":"Carcinogenesis"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"154485","DOI":"10.1016\/j.prp.2023.154485","article-title":"Liver cancer cell-secreted exosomes promote bone metastasis of liver cancer by facilitating osteoclast differentiation through the miR-574-5p\/BMP2 axis","volume":"245","author":"Li","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Tessitore, A., Cicciarelli, G., Del Vecchio, F., Gaggiano, A., Verzella, D., Fischietti, M., Mastroiaco, V., Vetuschi, A., Sferra, R., and Barnabei, R. (2016). MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: Study on C57BL\/6J mice. BMC Cancer, 16.","DOI":"10.1186\/s12885-015-2007-1"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"De la Cruz-Ojeda, P., Schmid, T., Boix, L., Moreno, M., Sapena, V., Praena-Fern\u00e1ndez, J.M., Castell, F.J., Falc\u00f3n-P\u00e9rez, J.M., Reig, M., and Br\u00fcne, B. (2022). miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma. Cells, 11.","DOI":"10.3390\/cells11172673"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S591","DOI":"10.1245\/s10434-014-3705-7","article-title":"Reprogramming using microRNA-302 improves drug sensitivity in hepatocellular carcinoma cells","volume":"21","author":"Koga","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_43","first-page":"237","article-title":"Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinoma","volume":"53","author":"Iwai","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.3892\/ijo.2016.3751","article-title":"Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN\/PI3K\/Akt\/Bad signaling pathway","volume":"49","author":"Feng","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1440-1827.2010.02526.x","article-title":"Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development","volume":"60","author":"Shigoka","year":"2010","journal-title":"Pathol. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.7150\/thno.43640","article-title":"Dysregulated Sp1\/miR-130b-3p\/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma","volume":"10","author":"Liao","year":"2020","journal-title":"Theranostics"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13287-016-0389-x","article-title":"Adipose-derived mesenchymal stem cells from patients with atherosclerotic renovascular disease have increased DNA damage and reduced angiogenesis that can be modified by hypoxia","volume":"7","author":"Saad","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1159\/000488734","article-title":"MicroRNA-214-5p Inhibits the Invasion and Migration of Hepatocellular Carcinoma Cells by Targeting Wiskott-Aldrich Syndrome Like","volume":"46","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood.2019003105","article-title":"Altered microRNA expression links IL6 and TNF-induced inflammaging with myeloid malignancy in humans and mice","volume":"135","author":"Grants","year":"2020","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Zimta, A.A., Cenariu, D., Irimie, A., Magdo, L., Nabavi, S.M., Atanasov, A.G., and Berindan-Neagoe, I. (2019). The Role of Nrf2 Activity in Cancer Development and Progression. Cancers, 11.","DOI":"10.3390\/cancers11111755"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Rui, T., Zhang, X., Feng, S., Huang, H., Zhan, S., Xie, H., Zhou, L., Ling, Q., and Zheng, S. (2020). The Similar Effects of miR-512-3p and miR-519a-2-5p on the Promotion of Hepatocellular Carcinoma: Different Tunes Sung With Equal Skill. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01244"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/cas.13177","article-title":"MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K\/Akt pathway","volume":"108","author":"Fu","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_53","first-page":"927","article-title":"The miR-873\/NDFIP1 axis promotes hepatocellular carcinoma growth and metastasis through the AKT\/mTOR-mediated Warburg effect","volume":"9","author":"Zhang","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"16227","DOI":"10.18632\/oncotarget.3970","article-title":"miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","article-title":"Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model","volume":"137","author":"Kota","year":"2009","journal-title":"Cell"},{"key":"ref_56","first-page":"830","article-title":"MicroRNA-766-3p Inhibits Tumour Progression by Targeting Wnt3a in Hepatocellular Carcinoma","volume":"41","author":"You","year":"2018","journal-title":"Mol. Cells"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3892\/mmr.2015.4500","article-title":"MicroRNA-148b targets Rho-associated protein kinase 1 to inhibit cell proliferation, migration and invasion in hepatocellular carcinoma","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"66922","DOI":"10.18632\/oncotarget.11877","article-title":"MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3892\/or.2016.4971","article-title":"miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway","volume":"36","author":"Liu","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.biopha.2016.09.056","article-title":"Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma","volume":"84","author":"Zhang","year":"2016","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.3892\/or.2017.5549","article-title":"miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion","volume":"37","author":"Liu","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3892\/ijo.2017.3852","article-title":"miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR\/STAT3\/AKT pathway in hepatocellular carcinoma","volume":"50","author":"Yu","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10456-018-9654-1","article-title":"The regulatory network of miR-141 in the inhibition of angiogenesis","volume":"22","author":"Dong","year":"2019","journal-title":"Angiogenesis"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bbrc.2017.06.050","article-title":"Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line","volume":"490","author":"Zhao","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_65","first-page":"905","article-title":"MicroRNA-33b inhibits cell proliferation in hepatocellular carcinoma via targeting SALL4","volume":"41","author":"Li","year":"2016","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban J. Cent. South. Univ. Med. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.bbrc.2017.03.110","article-title":"miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1","volume":"486","author":"Mahati","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1158\/0008-5472.CAN-08-4797","article-title":"MiR-122\/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells","volume":"69","author":"Fornari","year":"2009","journal-title":"Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e2999","DOI":"10.1038\/cddis.2017.356","article-title":"miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt\/\u03b2-catenin signaling through targeting BCL9","volume":"8","author":"Yang","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3748\/wjg.v25.i19.2279","article-title":"Mechanisms of hepatocellular carcinoma progression","volume":"25","author":"Ogunwobi","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/JHC.S347959","article-title":"Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes","volume":"10","author":"Ito","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Palma, R., Pronio, A., Romeo, M., Scognamiglio, F., Ventriglia, L., Ormando, V.M., Lamazza, A., Pontone, S., Federico, A., and Dallio, M. (2022). The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications. J. Clin. Med., 11.","DOI":"10.3390\/jcm11133649"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Oura, K., Morishita, A., and Masaki, T. (2020). Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218362"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.3748\/wjg.v24.i36.4104","article-title":"Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease","volume":"24","author":"Torres","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/hep.23100","article-title":"Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL\/6 mice","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Niture, S., Gadi, S., Qi, Q., Gyamfi, M.A., Varghese, R.S., Rios-Colon, L., Chimeh, U., Ressom, H.W., and Kumar, D. (2023). MicroRNA-483-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Cell Steatosis, and Fibrosis by Targeting PPAR\u03b1 and TIMP2. Cancers, 15.","DOI":"10.3390\/cancers15061715"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Wu, F., Zhang, F.Y., Tan, G.Q., Chen, W.J., Huang, B., Yan, L., Zhang, H.L., Chen, S., Jiao, Y., and Wang, B.L. (2021). Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08327-0"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","article-title":"Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications","volume":"166","author":"Mirza","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/carcin\/bgac037","article-title":"Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancer","volume":"43","author":"Peeney","year":"2022","journal-title":"Carcinogenesis"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.3748\/wjg.v26.i38.5759","article-title":"Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma","volume":"26","author":"Lau","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Stroffolini, T., and Stroffolini, G. (2023). A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma. Cancers, 15.","DOI":"10.3390\/cancers15082388"},{"key":"ref_81","first-page":"118","article-title":"Hepatitis B Virus Surface Antigen Promotes Stemness of Hepatocellular Carcinoma through Regulating MicroRNA-203a","volume":"11","author":"Qin","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"15330338211070689","DOI":"10.1177\/15330338211070689","article-title":"Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma","volume":"21","author":"Wang","year":"2022","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrg.2015.10","article-title":"Unique features of long non-coding RNA biogenesis and function","volume":"17","author":"Quinn","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: Metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-020-01293-4","article-title":"Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine","volume":"19","author":"Wen","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrgastro.2017.169","article-title":"Non-coding RNAs in hepatocellular carcinoma: Molecular functions and pathological implications","volume":"15","author":"Wong","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.omtn.2021.10.028","article-title":"Super-enhancer-driven lncRNA-DAW promotes liver cancer cell proliferation through activation of Wnt\/\u03b2-catenin pathway","volume":"26","author":"Liang","year":"2021","journal-title":"Mol. Therapy. Nucleic Acids"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/hep.30613","article-title":"Lnc-UCID Promotes G1\/S Transition and Hepatoma Growth by Preventing DHX9-Mediated CDK6 Down-regulation","volume":"70","author":"Wang","year":"2019","journal-title":"Hepatology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2696","article-title":"Emerging roles of E2Fs in cancer: An exit from cell cycle control","volume":"9","author":"Chen","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1002\/ctm2.220","article-title":"Long noncoding RNA CASC11 promotes hepatocarcinogenesis and HCC progression through EIF4A3-mediated E2F1 activation","volume":"10","author":"Song","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.gastro.2006.08.026","article-title":"Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA","volume":"132","author":"Panzitt","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"241","DOI":"10.18632\/oncotarget.6280","article-title":"Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1)","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_93","first-page":"659","article-title":"LncRNA HULC promots HCC growth by downregulating miR-29","volume":"41","author":"Zhu","year":"2019","journal-title":"Zhonghua Zhong Liu Za Zhi Chin. J. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cell.2007.05.022","article-title":"Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs","volume":"129","author":"Rinn","year":"2007","journal-title":"Cell"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jhep.2015.05.016","article-title":"Hotair mediates hepatocarcinogenesis through suppressing miRNA-218 expression and activating P14 and P16 signaling","volume":"63","author":"Fu","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"8457112","DOI":"10.1155\/2023\/8457112","article-title":"LncRNA CASC2 Regulate Cell Proliferation and Invasion by Targeting miR-155\/SOCS1 Axis in Hepatocellular Carcinoma","volume":"2023","author":"Yuan","year":"2023","journal-title":"J. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/jcb.26317","article-title":"Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR\/S6K1 signaling pathway","volume":"119","author":"Wang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1684\/ecn.2019.0432","article-title":"lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506\/GLI3","volume":"30","author":"Jin","year":"2019","journal-title":"Eur. Cytokine Netw."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Xiang, J., Deng, Y.Y., Liu, H.X., and Pu, Y. (2022). LncRNA MALAT1 Promotes PPAR\u03b1\/CD36-Mediated Hepatic Lipogenesis in Nonalcoholic Fatty Liver Disease by Modulating miR-206\/ARNT Axis. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.858558"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/0008-5472.CAN-16-1508","article-title":"Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation","volume":"77","author":"Malakar","year":"2017","journal-title":"Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jhep.2015.09.013","article-title":"Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122","volume":"64","author":"Liang","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2014.01.030","article-title":"Viral-human chimeric transcript predisposes risk to liver cancer development and progression","volume":"25","author":"Lau","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"26302","DOI":"10.1074\/jbc.M112.342113","article-title":"Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18","volume":"287","author":"Du","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"43770","DOI":"10.18632\/oncotarget.6087","article-title":"Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"D308","DOI":"10.1093\/nar\/gkx1107","article-title":"NONCODEV5: A comprehensive annotation database for long non-coding RNAs","volume":"46","author":"Fang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e3811","DOI":"10.1097\/MD.0000000000003811","article-title":"Comprehensive Circular RNA Profiling Reveals That hsa_circ_0005075, a New Circular RNA Biomarker, Is Involved in Hepatocellular Crcinoma Development","volume":"95","author":"Shang","year":"2016","journal-title":"Medicine"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.biopha.2018.01.150","article-title":"Emerging roles of hsa_circ_0005075 targeting miR-431 in the progress of HCC","volume":"99","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12094-015-1278-y","article-title":"Correlation between down-expression of miR-431 and clinicopathological significance in HCC tissues","volume":"17","author":"Pan","year":"2015","journal-title":"Clin. Transl. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbrc.2020.07.035","article-title":"CircRNA circ-0038718 promotes hepatocellular carcinoma progression through sponging miR-139-3p","volume":"533","author":"Sun","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Yang, G., Zhang, M., Zhao, Y., Pan, Y., Kan, M., Li, J., He, K., and Zhang, X. (2020). HNF-4\u03b1 inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0230450"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2147\/CMAR.S166740","article-title":"Screening differential circular RNA expression profiles reveal that hsa_circ_0128298 is a biomarker in the diagnosis and prognosis of hepatocellular carcinoma","volume":"10","author":"Chen","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4251\/wjgo.v11.i10.909","article-title":"Abnormally expressed circular RNAs as novel non-invasive biomarkers for hepatocellular carcinoma: A meta-analysis","volume":"11","author":"Jiang","year":"2019","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/21655979.2021.1878763","article-title":"Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma","volume":"12","author":"Cao","year":"2021","journal-title":"Bioengineered"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.7150\/ijms.45637","article-title":"Circular RNA Expression Profiles and the Pro-tumorigenic Function of CircRNA_10156 in Hepatitis B Virus-Related Liver Cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/JCMA.0000000000000230","article-title":"CircularRNA as novel biomarkers in liver diseases","volume":"83","author":"Chien","year":"2020","journal-title":"J. Chin. Med. Assoc. JCMA"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Yu, L., Gong, X., Sun, L., Zhou, Q., Lu, B., and Zhu, L. (2016). The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158347"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00432-016-2256-7","article-title":"The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma","volume":"143","author":"Xu","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.bbrc.2018.02.119","article-title":"CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324\/FZD5\/Wnt\/\u03b2-catenin axis","volume":"497","author":"Zhu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.29270","article-title":"Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression","volume":"66","author":"Han","year":"2017","journal-title":"Hepatology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/kjm2.12566","article-title":"Long noncoding RNA LINC01419 promotes hepatocellular carcinoma malignancy by mediating miR-485-5p\/LSM4 axis","volume":"38","author":"Sun","year":"2022","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s13402-020-00540-6","article-title":"LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity","volume":"43","author":"Dang","year":"2020","journal-title":"Cell. Oncol."},{"key":"ref_122","first-page":"9313680","article-title":"LINC01419 Promotes the Proliferation of Hepatoma Cells by Recruiting XRCC5 and Regulating Its Phosphorylation to Repair DNA Damage","volume":"2022","author":"Liu","year":"2022","journal-title":"Dis. Markers"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"11071","DOI":"10.18632\/aging.103321","article-title":"LINC01419 facilitates hepatocellular carcinoma growth and metastasis through targeting EZH2-regulated RECK","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging"},{"key":"ref_124","first-page":"4855","article-title":"Increased expression of long noncoding RNA AK021443 predicts worse clinical outcome in hepatocellular carcinoma","volume":"22","author":"Li","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/dna.2017.4030","article-title":"Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells","volume":"37","author":"Yang","year":"2018","journal-title":"DNA Cell Biol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Chen, T., Pei, J., Wang, J., Luo, R., Liu, L., Wang, L., and Jia, H. (2019). HBx-related long non-coding RNA 01152 promotes cell proliferation and survival by IL-23 in hepatocellular carcinoma. Biomed. Pharmacother. Biomed. Pharmacother., 115.","DOI":"10.1016\/j.biopha.2019.108877"},{"key":"ref_127","first-page":"555","article-title":"Circ-RNF13, as an oncogene, regulates malignant progression of HBV-associated hepatocellular carcinoma cells and HBV infection through ceRNA pathway of circ-RNF13\/miR-424-5p\/TGIF2","volume":"21","author":"Chen","year":"2021","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/carcin\/bgz154","article-title":"Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma","volume":"41","author":"Zhu","year":"2020","journal-title":"Carcinogenesis"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1097\/CAD.0000000000001211","article-title":"Circ_0027089 regulates NACC1 by targeting miR-136-5p to aggravate the development of hepatitis B virus-related hepatocellular carcinoma","volume":"33","author":"He","year":"2022","journal-title":"Anti-Cancer Drugs"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/imm.13456","article-title":"Cellular landscape of tumour microenvironment in prostate cancer","volume":"168","author":"Feng","year":"2023","journal-title":"Immunology"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1002\/ctm2.422","article-title":"Single-cell analyses reveal suppressive tumor microenvironment of human colorectal cancer","volume":"11","author":"Mei","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune Responses in the Liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jcmgh.2023.01.007","article-title":"Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells","volume":"15","author":"Huang","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Zhan, T., Gao, X., Wang, G., Li, F., Shen, J., Lu, C., Xu, L., Li, Y., and Zhang, J. (2021). Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.626663"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Ouyang, X., Lv, L., Zhao, Y., Zhang, F., Hu, Q., Li, Z., Zhu, D., and Li, L. (2021). ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.801506"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/jcp.29194","article-title":"LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-\u03b2 pathway and IL-6\/JAK2\/STAT3 pathway","volume":"235","author":"Shi","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-020-01213-6","article-title":"Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p\/snail\/DPP4 axis","volume":"19","author":"Huang","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41590-019-0321-5","article-title":"Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth","volume":"20","author":"Hollande","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/cas.15365","article-title":"Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells","volume":"113","author":"Huang","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41580-018-0007-0","article-title":"Contextual determinants of TGF\u03b2 action in development, immunity and cancer","volume":"19","author":"David","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ni1549","article-title":"Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer","volume":"9","author":"Tone","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Yu, W., Wang, S., Wang, Y., Chen, H., Nie, H., Liu, L., Zou, X., Gong, Q., and Zheng, B. (2023). MicroRNA: Role in macrophage polarization and the pathogenesis of the liver fibrosis. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1147710"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12943-021-01343-5","article-title":"Epigenetic silencing of miR-144\/451a cluster contributes to HCC progression via paracrine HGF\/MIF-mediated TAM remodeling","volume":"20","author":"Zhao","year":"2021","journal-title":"Mol. Cancer"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12943-019-1047-6","article-title":"Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: Challenges and opportunities","volume":"18","author":"Lu","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Han, Q., Zhao, H., Jiang, Y., Yin, C., and Zhang, J. (2019). HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape. Cells, 8.","DOI":"10.3390\/cells8060558"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Li, X., Lei, Y., Wu, M., and Li, N. (2018). Regulation of Macrophage Activation and Polarization by HCC-Derived Exosomal lncRNA TUC339. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19102958"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1947601913499020","article-title":"Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer","volume":"4","author":"Kogure","year":"2013","journal-title":"Genes Cancer"},{"key":"ref_150","first-page":"1642","article-title":"MicroRNA-206 promotes the recruitment of CD8(+) T cells by driving M1 polarisation of Kupffer cells","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.21037\/atm-20-2554a","article-title":"The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer","volume":"8","author":"Tang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Liu, Y., Zhang, X., Zhang, J., Tan, J., Li, J., and Song, Z. (2020). Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.596679"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7150\/thno.48206","article-title":"Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer","volume":"11","author":"Zhu","year":"2021","journal-title":"Theranostics"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Xu, Z., Peng, B., Liang, Q., Chen, X., Cai, Y., Zeng, S., Gao, K., Wang, X., Yi, Q., and Gong, Z. (2021). Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.719175"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1111\/febs.16034","article-title":"Emerging roles of ferroptosis in the tumor immune landscape: From danger signals to anti-tumor immunity","volume":"289","author":"Shi","year":"2022","journal-title":"FEBS J."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"118305","DOI":"10.1016\/j.lfs.2020.118305","article-title":"LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53","volume":"260","author":"Lu","year":"2020","journal-title":"Life Sci."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ymthe.2020.09.024","article-title":"A Nuclear Long Non-Coding RNA LINC00618 Accelerates Ferroptosis in a Manner Dependent upon Apoptosis","volume":"29","author":"Wang","year":"2021","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Liu, C., Gao, Y., Ni, J., Chen, S., Hu, Q., Wang, C., Hu, M., and Chen, M. (2022). The ferroptosis-related long non-coding RNAs signature predicts biochemical recurrence and immune cell infiltration in prostate cancer. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09876-8"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.18632\/aging.204073","article-title":"Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma","volume":"14","author":"Yang","year":"2022","journal-title":"Aging"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s10482-020-01474-7","article-title":"Human gut microbiota\/microbiome in health and diseases: A review","volume":"113","author":"Gomaa","year":"2020","journal-title":"Antonie Leeuwenhoek"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/153537020422900702","article-title":"Commensal bacteria, redox stress, and colorectal cancer: Mechanisms and models","volume":"229","author":"Huycke","year":"2004","journal-title":"Exp. Biol. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/cmi.12308","article-title":"Defining dysbiosis and its influence on host immunity and disease","volume":"16","author":"Petersen","year":"2014","journal-title":"Cell. Microbiol."},{"key":"ref_164","first-page":"26191","article-title":"Dysbiosis of the gut microbiota in disease","volume":"26","author":"Carding","year":"2015","journal-title":"Microb. Ecol. Health Dis."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21037\/hbsn.2017.12.07","article-title":"Targeting gut microbiota in hepatocellular carcinoma: Probiotics as a novel therapy","volume":"7","author":"Wan","year":"2018","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.transproceed.2016.01.077","article-title":"Profile of Gut Microbiota Associated with the Presence of Hepatocellular Cancer in Patients with Liver Cirrhosis","volume":"48","author":"Wronka","year":"2016","journal-title":"Transplant. Proc."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Lu, H., Ren, Z., Li, A., Zhang, H., Jiang, J., Xu, S., Luo, Q., Zhou, K., Sun, X., and Zheng, S. (2016). Deep sequencing reveals microbiota dysbiosis of tongue coat in patients with liver carcinoma. Sci. Rep., 6.","DOI":"10.1038\/srep33142"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Elinav","year":"2012","journal-title":"Nature"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Shepard, C.R. (2020). TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.613639"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s10620-010-1447-3","article-title":"Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: Association with toll-like receptor 4 expression and plasma levels of interleukin 8","volume":"56","author":"Shanab","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Jeon, S.G., Kayama, H., Ueda, Y., Takahashi, T., Asahara, T., Tsuji, H., Tsuji, N.M., Kiyono, H., Ma, J.S., and Kusu, T. (2012). Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002714"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.livres.2017.11.005","article-title":"Gut microbiota, fatty liver disease, and hepatocellular carcinoma","volume":"2","author":"Chu","year":"2018","journal-title":"Liver Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1788891","DOI":"10.1080\/19490976.2020.1788891","article-title":"Gut microbiota regulate tumor metastasis via circRNA\/miRNA networks","volume":"12","author":"Zhu","year":"2020","journal-title":"Gut Microbes"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Arunima, A., van Schaik, E.J., and Samuel, J.E. (2023). The emerging roles of long non-coding RNA in host immune response and intracellular bacterial infections. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1160198"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"118579","DOI":"10.1016\/j.lfs.2020.118579","article-title":"Roles of long noncoding RNAs in bacterial infection","volume":"263","author":"Wen","year":"2020","journal-title":"Life Sci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41392-021-00779-x","article-title":"Roles and mechanisms of exosomal non-coding RNAs in human health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.1102281108","article-title":"miR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling","volume":"108","author":"Goedeke","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nature10112","article-title":"MicroRNAs 103 and 107 regulate insulin sensitivity","volume":"474","author":"Trajkovski","year":"2011","journal-title":"Nature"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"eaav1892","DOI":"10.1126\/scitranslmed.aav1892","article-title":"The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs","volume":"11","author":"Virtue","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"8994","DOI":"10.3748\/wjg.v21.i30.8994","article-title":"Therapeutic potential of small interfering RNAs\/micro interfering RNA in hepatocellular carcinoma","volume":"21","author":"Farra","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Koustas, E., Trifylli, E.M., Sarantis, P., Papadopoulos, N., Papanikolopoulos, K., Aloizos, G., Damaskos, C., Garmpis, N., Garmpi, A., and Matthaios, D. (2023). An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087168"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Li, J., Bao, H., Huang, Z., Liang, Z., Wang, M., Lin, N., Ni, C., and Xu, Y. (2023). Little things with significant impact: miRNAs in hepatocellular carcinoma. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1191070"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/ijc.34146","article-title":"Integrin alpha 6 is upregulated and drives hepatocellular carcinoma progression through integrin \u03b16\u03b24 complex","volume":"151","author":"Zheng","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.7150\/ijbs.72367","article-title":"The interactions between integrin \u03b1(5)\u03b2(1) of liver cancer cells and fibronectin of fibroblasts promote tumor growth and angiogenesis","volume":"18","author":"Peng","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1038\/ncomms4869","article-title":"Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice","volume":"5","author":"Bogorad","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jhep.2015.01.014","article-title":"ECT2 regulates the Rho\/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma","volume":"62","author":"Chen","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.18632\/oncotarget.2316","article-title":"Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1101\/gad.244368.114","article-title":"CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma","volume":"28","author":"Huang","year":"2014","journal-title":"Genes Dev."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd4685","article-title":"Clinical experiences with systemically administered siRNA-based therapeutics in cancer","volume":"14","author":"Zuckerman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1038\/sj.onc.1207782","article-title":"Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: Identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas","volume":"23","author":"Yamada","year":"2004","journal-title":"Oncogene"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ncrna.2022.11.005","article-title":"MicroRNA-122 mimic\/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma","volume":"8","author":"Hassan","year":"2023","journal-title":"Non-Coding RNA Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.nano.2013.05.007","article-title":"Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor","volume":"9","author":"Hsu","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Bozzato, A.M., Martingano, P., Pozzi Mucelli, R.A., Cavallaro, M.F.M., Cesarotto, M., Marcello, C., Tiribelli, C., Pascut, D., Pizzolato, R., and Pozzi Mucelli, F. (2022). MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View. Diagnostics, 12.","DOI":"10.3390\/diagnostics12020374"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-019-1059-5","article-title":"MicroRNA-34 family: A potential tumor suppressor and therapeutic candidate in cancer","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1021\/acsmaterialsau.2c00042","article-title":"Gold Nanoconjugates for miRNA Modulation in Cancer Therapy: From miRNA Silencing to miRNA Mimics","volume":"2","author":"Sousa","year":"2022","journal-title":"ACS Mater. Au"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1080\/21691401.2018.1489266","article-title":"Gold nano-particles (AuNPs) carrying miR-326 targets PDK1\/AKT\/c-myc axis in hepatocellular carcinoma","volume":"47","author":"Mo","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Ladd, A.D., Duarte, S., Sahin, I., and Zarrinpar, A. (2023). Mechanisms of drug resistance in HCC. Hepatology.","DOI":"10.1097\/HEP.0000000000000237"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/bs.podrm.2018.11.003","article-title":"Sorafenib","volume":"44","author":"Abdelgalil","year":"2019","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/cas.13006","article-title":"miR-181a induces sorafenib resistance of hepatocellular carcinoma cells through downregulation of RASSF1 expression","volume":"107","author":"Azumi","year":"2016","journal-title":"Cancer Sci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3892\/or.2015.4030","article-title":"miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN","volume":"34","author":"Liu","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.26369","article-title":"MicroRNA-216a\/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer","volume":"58","author":"Xia","year":"2013","journal-title":"Hepatology"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/sjg.SJG_4_20","article-title":"LncRNA NEAT1 modulates sorafenib resistance in hepatocellular carcinoma through regulating the miR-149-5p\/AKT1 axis","volume":"26","author":"Niu","year":"2020","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1073274818789361","DOI":"10.1177\/1073274818789361","article-title":"Lenvatinib: A Promising Molecular Targeted Agent for Multiple Cancers","volume":"25","author":"Suyama","year":"2018","journal-title":"Cancer Control. J. Moffitt Cancer Cent."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00535-019-01642-1","article-title":"REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: An analysis of Japanese subset","volume":"55","author":"Yamashita","year":"2020","journal-title":"J. Gastroenterol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s13402-021-00605-0","article-title":"MT1JP-mediated miR-24-3p\/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis","volume":"44","author":"Yu","year":"2021","journal-title":"Cell. Oncol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/JHC.S349369","article-title":"MicroRNA-128-3p Mediates Lenvatinib Resistance of Hepatocellular Carcinoma Cells by Downregulating c-Met","volume":"9","author":"Xu","year":"2022","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41419-022-04652-9","article-title":"Downregulation of MUC15 by miR-183-5p.1 promotes liver tumor-initiating cells properties and tumorigenesis via regulating c-MET\/PI3K\/AKT\/SOX2 axis","volume":"13","author":"Han","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12672-023-00673-8","article-title":"Overexpression of the lncRNA HOTAIRM1 promotes lenvatinib resistance by downregulating miR-34a and activating autophagy in hepatocellular carcinoma","volume":"14","author":"Gu","year":"2023","journal-title":"Discover. Oncol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nm.3679","article-title":"In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer","volume":"20","author":"Rudalska","year":"2014","journal-title":"Nat. Med."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"12916","DOI":"10.18632\/oncotarget.2682","article-title":"Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB\/microRNA-21\/PTEN signaling pathway","volume":"5","author":"Zhang","year":"2014","journal-title":"Oncotarget"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41419-021-04491-0","article-title":"MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1","volume":"13","author":"Dong","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"109127","DOI":"10.1016\/j.intimp.2022.109127","article-title":"siRNA targeting PD-L1 delivered with attenuated Salmonella enhanced the anti-tumor effect of lenvatinib on mice bearing Hepatocellular carcinoma","volume":"111","author":"Chen","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.4161\/cbt.7.10.6539","article-title":"siRNA-mediated inhibition of hTERT enhances chemosensitivity of hepatocellular carcinoma","volume":"7","author":"Guo","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"101736","DOI":"10.1016\/j.clinre.2021.101736","article-title":"Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review","volume":"45","author":"Zhao","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12943-019-1086-z","article-title":"The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma","volume":"18","author":"Wei","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Ding, B., Lou, W., Xu, L., and Fan, W. (2018). Non-coding RNA in drug resistance of hepatocellular carcinoma. Biosci. Rep., 38.","DOI":"10.1042\/BSR20180915"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/21\/5178\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:13:05Z","timestamp":1760130785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/21\/5178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":219,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["cancers15215178"],"URL":"https:\/\/doi.org\/10.3390\/cancers15215178","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]}}}